$2.98 Billion is the total value of HealthCor Management, L.P.'s 40 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 80.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $251,230,000 | – | 1,000,000 | +100.0% | 8.42% | – |
| LH | Buy | LABORATORY CORP AMER HLDGS | $237,369,000 | +12.0% | 1,572,290 | +14.3% | 7.95% | +4.0% |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $198,211,000 | +204.2% | 1,692,810 | +233.6% | 6.64% | +182.5% |
| AET | Buy | AETNA INC NEW | $179,947,000 | +31.7% | 1,131,674 | +25.7% | 6.03% | +22.3% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $120,133,000 | +11.6% | 3,214,679 | +33.8% | 4.03% | +3.6% |
| AGN | Buy | ALLERGAN PLC | $117,479,000 | +131.6% | 573,210 | +174.7% | 3.94% | +115.0% |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $96,805,000 | +13.1% | 2,578,040 | +43.7% | 3.24% | +5.1% |
| JNJ | New | JOHNSON & JOHNSON | $88,803,000 | – | 683,050 | +100.0% | 2.98% | – |
| ABBV | Buy | ABBVIE INC | $87,644,000 | +51.2% | 986,320 | +23.4% | 2.94% | +40.4% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $75,009,000 | +292.4% | 382,990 | +271.5% | 2.51% | +264.3% |
| THC | New | TENET HEALTHCARE CORP | $74,460,000 | – | 4,531,932 | +100.0% | 2.50% | – |
| INCY | New | INCYTE CORP | $69,875,000 | – | 598,550 | +100.0% | 2.34% | – |
| LIVN | Buy | LIVANOVA PLC | $65,263,000 | +166.6% | 931,530 | +132.9% | 2.19% | +147.4% |
| HUM | Buy | HUMANA INC | $63,556,000 | +6.0% | 260,870 | +4.7% | 2.13% | -1.5% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $53,347,000 | +131.3% | 647,420 | +162.9% | 1.79% | +114.9% |
| VAR | Buy | VARIAN MED SYS INCput | $50,030,000 | +384.8% | 500,000 | +400.0% | 1.68% | +350.8% |
| INCR | New | INC RESH HLDGS INCcl a | $48,669,000 | – | 930,582 | +100.0% | 1.63% | – |
| MRK | New | MERCK & CO INC | $44,263,000 | – | 691,280 | +100.0% | 1.48% | – |
| HRC | Buy | HILL ROM HLDGS INC | $43,273,000 | +334.9% | 584,770 | +367.8% | 1.45% | +303.9% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $41,357,000 | – | 1,010,930 | +100.0% | 1.39% | – |
| AGN | New | ALLERGAN PLCcall | $30,743,000 | – | 150,000 | +100.0% | 1.03% | – |
| MNKKQ | New | MALLINCKRODT PUB LTD COcall | $29,896,000 | – | 800,000 | +100.0% | 1.00% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INCcall | $29,273,000 | – | 250,000 | +100.0% | 0.98% | – |
| ZTS | Buy | ZOETIS INCcl a | $25,417,000 | +341.3% | 398,640 | +331.7% | 0.85% | +309.6% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $20,045,000 | +59.3% | 687,170 | +51.4% | 0.67% | +48.0% |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $10,660,000 | – | 235,000 | +100.0% | 0.36% | – |
| PFE | New | PFIZER INC | $8,838,000 | – | 247,570 | +100.0% | 0.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.